ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0468

Clinical Outcomes and Consumption in Extended Hemodialysis and Online Hemodiafiltration: Multicenter Analysis

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Martinez Vaquera, Shaira, Diaverum Renal Services, Madrid, Spain
  • Useche Bonilla, Gustavo Andres, Diaverum Renal Services, Madrid, Spain
  • Sorribes López, Maria Paz, Diaverum Renal Services, Madrid, Spain
  • Dal Maso, Mirco, Diaverum Renal Services, Madrid, Spain

Group or Team Name

  • Diaverum Valencia, Spain.
Background

Extended hemodialysis (HDx) combines diffusive and convective transport using cut-off membranes. Considering its potential as an alternative to online hemodiafiltration (OL-HDF), we conducted a comparative study between the two techniques.

Methods

A retrospective analysis in 10 outpatient dialysis centers during 2024. Patients on HDx or OL-HDF for at least 360 days, with 90 recorded treatments, were included. Patients on incremental or palliative hemodialysis were excluded. Demographic, clinical, and laboratory variables (at baseline, 6 and 12 months), emergency hospitalizations, and annual consumption of dialysis medications (sodium heparin, erythropoiesis-stimulating agents [ESA], iron, paricalcitol, etecalcetide) were collected. The comparative analysis used Propensity Score Matching (PSM) and Inverse Probability of Treatment Weighting (IPTW) with Doubly Robust Estimation, using R (v4.4.3). The final cohort included 40 patients on HDx and 253 on OL-HDF.

Results

After adjusting for age, gender, time on dialysis, diabetes, hypertension, vascular access, Charlson and Karnofsky indices, frequency and duration of sessions, and average annual blood flow (Qb), statistically significant differences were found: hemoglobin levels and transferrin saturation index (TSI) were higher in HDx, and serum potassium was lower. No differences were observed in albumin, β2-microglobulin, or the risk of urgent hospitalization. Regarding medication use, HDx showed significantly lower use of iron sucrose and etecalcetide and higher use of sodium heparin. The trend toward lower use of AEE and paricalcitol in HDx did not reach statistical significance

Conclusion

Although differences in hemoglobin, IST, and potassium were identified, these are not considered clinically relevant. In our experience, HDx and HDF-OL showed comparable efficacy in median solute clearance and analytical parameters with no differences in urgent hospitalization events. HDx may offer additional advantages, such as reduced consumption of certain drugs and potential water savings compared to HDF-OL.

Digital Object Identifier (DOI)